Discover
Friday, May 30 - Tuesday, June 3
ASCO 2025
Booth #11059
Join our executive team and experts in Chicago
Accelerate your oncology development with a purpose-built, integrated CRO. Precision combines scientific expertise with responsive operations across 2,500+ completed trials. Our comprehensive lab and clinical solutions transform your cancer innovations into life-changing therapies, delivering faster, cost-efficient results.
Drop by our booth #11059 or complete the form below to book a meeting with our experts at ASCO.
Sofia Baig, President, Clinical Solutions
The Precision difference
At Precision, we are committed to being the most reliable CRO in the industry, delivering on our promises with unwavering expertise and transparency. Our team excels in handling complex trials in oncology, fostering innovation and cross-functional collaboration to accelerate development timelines. By investing in next-generation technologies, we enhance clinical data access, improve decision-making, and streamline processes. This commitment helps deliver life-changing therapies efficiently, making Precision a trusted partner in advancing medicine and shaping the future of medicine.
Meet our executive leaders
-
Margaret Keegan
Chief Executive Officer, Precision Medicine Group
-
Chad Clark
President and Chief Operating Officer, Precision Medicine Group
-
Matt Grow
Chief Commercial Officer, Precision for Medicine
-
Matt Arnold
President, Translational Sciences, Precision for Medicine
-
Harpreet Singh, MD
Chief Medical Officer, Precision for Medicine
-
Deborah Phippard, PhD
Chief Scientific Officer, Precision for Medicine
-
Darren Davis, PhD
SVP, Global Digital Pathology, Genomics and Liquid Biopsy Solutions
-
Andrea Cotton-Berry
Global Head of Strategic Development, Precision for Medicine
Book time with our experts!
Contact us using the form below and our team will reach out to set up a dedicated meeting time at ASCO.
Find Precision for Medicine at booth #11059
ASCO 2025
McCormick Place, 2301 S Martin Luther King Dr, Chicago, IL 60616, United States
Exhibiting hours:
May 31 – June 2 - 09:00AM - 05:00PM
Harpreet Singh, MD, CMO and Former FDA Oncology Division Director
FDA approvals revolutionizing cancer research
2024 was a remarkable year for cancer and rare disease treatments, with the FDA approving several new and innovative therapies. In this video, Precision’s Chief Medical Officer and Former FDA Oncology Division Director, Harpreet Singh, MD, shares the top three approvals that will drive cancer treatment advancements in 2025.
Enhance early phase oncology with seamless phase 1-2 designs
Precision's cross-functional experts have executed 46 seamless oncology trials in the past 3 years. This eBook contains key considerations and best practices that are grounded in real-world experience to help you navigate the road ahead.
- Prestudy Strategy & Planning
- Execution Strategies
- Selecting a CRO
Oncology development insights from Precision experts
Stay informed with the latest insights from our experts, who share knowledge, trends, and success stories from the forefront of clinical research.
Progress in Gastrointestinal Oncology: 5 Key Insights from ASCO GI
Clinical Trials - Early Phase Research - Oncology
Phase 1-2 Case Study: Oncology Trial Success and Proactive Partnership
|
Clinical Trials - Regulatory - Oncology
FDA's Vision for Multiregional Clinical Trials in Oncology
|
Specialized capabilities in every stage of clinical development
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.
-
Discover Explore
Global CRO
ServicesExploreAward-winning CRO with deep oncology and rare disease expertise
-
Discover Explore
Global Laboratory
ServicesExploreExceptional translational and biomarker sciences with global central lab services
-
Discover BiospecimensBiospecimens
-
Discover Diagnostics & CDxDiagnostics & CDx
-
Discover Data IntelligenceData Intelligence
-
Discover CommercializationCommercialization